Vai al contenuto principale della pagina

Feature Paper in Antibiotics for 2019



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Lipman Jeffrey Visualizza persona
Titolo: Feature Paper in Antibiotics for 2019 Visualizza cluster
Pubblicazione: Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica: 1 electronic resource (282 p.)
Soggetto topico: Medicine
Soggetto non controllato: Antimicrobial resistance
antibiotics
antimicrobial stewardship
inappropriate prescribing
days of therapy
Start Smart then Focus
piperine
piperlongumine
antibacterial
antifungal
synergy
non-target feed
florfenicol
thiamfenicol
chloramfenicol
HPLC-MS/MS
validation
swine
out-of-hours care
primary care
quality of care
quality indicators
practitioners cooperative
antibiotic stewardship
fluoroquinolones
guidelines
urinary tract infections
quality improvement
general practitioners
guideline
health inequalities
health equity assessment tool
public health
Enterobacteriaceae
carbapenem-resistant
CRE
antibiotic resistance
antimicrobials
bacteriophages
biofilms
novel antimicrobials
Antibiotics
resistance
broad-spectrum agents
hospital epidemiology
antibiotic utilization
infection control
infection prevention
Pseudomonas aeruginosa
Acinetobacter baumannii
extended-spectrum beta-lactamases
carbapenem-resistant Enterobacteriaceae
methicillin-resistant Staphylococcus aureus
clinical trials
infectious disease
phage therapy
silver complexes
camphorimine
anti-Candida activity
antifungals
antibacterials
efflux inhibitors
efflux pumps
erm(41)
mutations
mycobacteria
verapamil
actinomycetes
bioactivity
polyketides
polyketide synthases
biosynthesis
antimicrobial resistance
economic evaluation
cost-utility analysis
cost-effectiveness analysis
policy analysis
One Health
Singapore
antibiotic prescribing
implementation
behavior change
stakeholder consultation
Persona (resp. second.): LipmanJeffrey
Sommario/riassunto: There has been much speculation about a possible antibiotic Armageddon; this would be the result of having untreatable post-operative infections, and similarly untreatable complications after chemotherapy. The now famous “O’Neill Report” (https://amr-review.org/) suggests that more people could die from resistant bacterial infections by 2050 than from cancer. We are still learning about all the subtle drivers of antibiotic resistance, and realizing that we need a single “whole of health” co-ordinated policy. We ingest what we sometimes feed to animals. There do not seem to be any new classes of antibiotics on our horizon. Perhaps something that has been around “forever” will come to our rescue—bacteriophages! Nevertheless, we have to do things differently, use antibiotics appropriately, for the correct indication, for the correct duration and with the correct dose, and with that, practice good antibiotic stewardship. Whilst by no means comprehensive, this book does cover some of the many topics of antibiotic stewardship. It also addresses some of the older antibiotics, some new combinations, and even some new agents. Last, and by no means least, there are two excellent articles on bacteriophages.
Titolo autorizzato: Feature Paper in Antibiotics for 2019  Visualizza cluster
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910557689603321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui